methylprednisolone acetate has been researched along with Disease Models, Animal in 28 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoporosis was induced by injecting methylprednisolone acetate (21 mg/kg) for the period of 6 weeks, and the rats were treated with cimiracemate A 5 and 10 mg/kg, p." | 7.91 | Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling. ( Ding, Z; Shi, H; Yang, W, 2019) |
| "This study compared the effect of monotherapy of colistin, tigecycline, and their combination in sepsis model of mice." | 7.80 | Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination. ( Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G, 2014) |
| "The study included 20 Sprague-Dawley rats injected once with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle to induce osteonecrosis." | 7.80 | Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats. ( Göksel, F; Hatay Gölge, U; Kaymaz, B; Kömürcü, E; Nusran, G; Oktay, M, 2014) |
| "Lacidipine is a potent dihydropyridine calcium channel blocker used for management of hypertension and atherosclerosis." | 3.96 | Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine. ( Abdel Halim, SA; Badr-Eldin, SM; Naguib, MJ; Salah, S, 2020) |
| "Osteoporosis was induced by injecting methylprednisolone acetate (21 mg/kg) for the period of 6 weeks, and the rats were treated with cimiracemate A 5 and 10 mg/kg, p." | 3.91 | Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling. ( Ding, Z; Shi, H; Yang, W, 2019) |
| "This study compared the effect of monotherapy of colistin, tigecycline, and their combination in sepsis model of mice." | 3.80 | Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination. ( Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G, 2014) |
| "The study included 20 Sprague-Dawley rats injected once with 20 mg/kg of methylprednisolone acetate into the right gluteus medius muscle to induce osteonecrosis." | 3.80 | Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats. ( Göksel, F; Hatay Gölge, U; Kaymaz, B; Kömürcü, E; Nusran, G; Oktay, M, 2014) |
| "Pravastatin, as a statin, was administered in the drinking water for 4 weeks." | 1.38 | Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats. ( Kumagai, K; Miyata, N; Niwa, M; Nozaki, Y, 2012) |
| "Tadalafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)." | 1.36 | Protective effects of tadalafil on experimental spinal cord injury in rats. ( Güven, EO; Oktar, S; Ozgiray, E; Serarslan, Y; Söğüt, S; Yilmaz, N; Yönden, Z; Yurtseven, T, 2010) |
| "Probucol and warfarin were administered beginning 1 to 2 weeks prior to steroid injection." | 1.35 | Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. ( Hirota, Y; Iwamoto, Y; Kondo, K; Miyanishi, K; Motomura, G; Yamamoto, T, 2008) |
| "The prevalence and severity of polycystic kidney disease (PKD) induced by glucocorticoids in mice can be predicted by a mathematical "threshold" model." | 1.29 | Na-K ATPase activity in murine glucocorticoid induced polycystic kidney disease in vivo. ( Crocker, JF; Ogborn, MR, 1993) |
| "Strongyloidiasis is the most common endemic helminthiasis in several of the world's industrialized nations, yet relatively little is known about its basic biology and immunobiology because a practical rodent model for the investigation of this clinically important parasitism is lacking." | 1.29 | Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus). ( Bhopale, VM; Megyeri, Z; Nolan, TJ; Schad, GA, 1993) |
| "Cyst formation in polycystic kidney disease (PKD) involves proliferation of cyst lining epithelial and changes in trans-epithelial fluid and electrolyte transport." | 1.29 | Renal tubule Na,K-ATPase polarity in glucocorticoid-induced polycystic kidney disease. ( Grimm, PC; Ogborn, MR; Sareen, S, 1993) |
| "Cystic change in polycystic kidney disease (PKD) is associated with epithelial hyperplasia, altered fluid and electrolyte transport, and de-differentiation of renal tubular epithelium." | 1.29 | Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease. ( Ogborn, MR; Sareen, S, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Naguib, MJ | 1 |
| Salah, S | 1 |
| Abdel Halim, SA | 1 |
| Badr-Eldin, SM | 1 |
| Rijsdijk, M | 1 |
| Agalave, NM | 1 |
| van Wijck, AJM | 1 |
| Kalkman, CJ | 1 |
| Ramachandran, R | 1 |
| Baharpoor, A | 1 |
| Svensson, CI | 1 |
| Yaksh, TL | 1 |
| Ding, Z | 1 |
| Shi, H | 1 |
| Yang, W | 1 |
| Demiraslan, H | 1 |
| Dinc, G | 1 |
| Ahmed, SS | 1 |
| Elmali, F | 1 |
| Metan, G | 1 |
| Alp, E | 1 |
| Doganay, M | 1 |
| Zhao, G | 1 |
| Yamamoto, T | 4 |
| Motomura, G | 3 |
| Yamaguchi, R | 1 |
| Ikemura, S | 1 |
| Iwasaki, K | 1 |
| Iwamoto, Y | 4 |
| Kömürcü, E | 1 |
| Oktay, M | 1 |
| Kaymaz, B | 1 |
| Hatay Gölge, U | 1 |
| Göksel, F | 1 |
| Nusran, G | 1 |
| Pengde, K | 1 |
| Fuxing, P | 1 |
| Bin, S | 1 |
| Jing, Y | 1 |
| Jingqiu, C | 1 |
| Miyanishi, K | 2 |
| Kondo, K | 1 |
| Hirota, Y | 1 |
| Kabata, T | 1 |
| Matsumoto, T | 1 |
| Yagishita, S | 1 |
| Wakayama, T | 1 |
| Iseki, S | 1 |
| Tomita, K | 1 |
| Serarslan, Y | 1 |
| Yönden, Z | 1 |
| Ozgiray, E | 1 |
| Oktar, S | 1 |
| Güven, EO | 1 |
| Söğüt, S | 1 |
| Yilmaz, N | 1 |
| Yurtseven, T | 1 |
| Wang, L | 1 |
| Wang, N | 1 |
| Li, M | 1 |
| Wang, K | 1 |
| Miyata, N | 2 |
| Kumagai, K | 2 |
| Osaki, M | 1 |
| Murata, M | 1 |
| Tomita, M | 1 |
| Hozumi, A | 1 |
| Nozaki, Y | 2 |
| Niwa, M | 2 |
| Lu, BB | 1 |
| Li, KH | 1 |
| Maravilla, P | 1 |
| Garza-Rodriguez, A | 1 |
| Gomez-Diaz, B | 1 |
| Jimenez-Gonzalez, DE | 1 |
| Toral-Bastida, E | 1 |
| Martinez-Ocaña, J | 1 |
| West, B | 1 |
| Molina, N | 1 |
| Garcia-Cortes, R | 1 |
| Kawa-Karasik, S | 1 |
| Romero-Valdovinos, M | 1 |
| Avila-Ramirez, G | 1 |
| Flisser, A | 1 |
| Ding, S | 1 |
| Peng, H | 1 |
| Fang, HS | 1 |
| Zhou, JL | 1 |
| Wang, Z | 1 |
| Kang, PD | 1 |
| Shen, B | 1 |
| Yang, J | 1 |
| Dang, HS | 1 |
| Pei, FX | 1 |
| Nishida, K | 1 |
| Jingushi, S | 2 |
| Bagwell, CE | 1 |
| Ferguson, WW | 1 |
| Kerlin, RL | 1 |
| Nolan, TJ | 2 |
| Schad, GA | 2 |
| Ogborn, MR | 3 |
| Crocker, JF | 1 |
| Megyeri, Z | 1 |
| Bhopale, VM | 1 |
| Sareen, S | 2 |
| Grimm, PC | 1 |
| Irisa, T | 1 |
| Yamashita, A | 1 |
| Noguchi, Y | 1 |
| Saari, H | 1 |
| Tulamo, RM | 1 |
| Konttinen, YT | 1 |
| Sorsa, T | 1 |
| Sanfilippo, JS | 1 |
| Cox, JG | 1 |
| Nealon, NA | 1 |
| Barrows, GH | 1 |
| Fujita, H | 1 |
28 other studies available for methylprednisolone acetate and Disease Models, Animal
| Article | Year |
|---|---|
Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine.
Topics: Administration, Intranasal; Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; | 2020 |
Effect of intrathecal glucocorticoids on the central glucocorticoid receptor in a rat nerve ligation model.
Topics: Animals; Disease Models, Animal; Glucocorticoids; Hyperalgesia; Injections, Spinal; Ligation; Male; | 2017 |
Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Cells, Cultured; Cinnamates; Disease Mod | 2019 |
Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Dose-Response Relatio | 2014 |
Cholesterol- and lanolin-rich diets may protect against steroid-induced osteonecrosis in rabbits.
Topics: Animals; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Diet; Disease Models, Animal; Fem | 2013 |
Preventive effects of coenzyme Q10 (CoQ10) on steroid-induced osteonecrosis in rats.
Topics: Animals; Disease Models, Animal; Femur Head; Glucocorticoids; Glutathione; Malondialdehyde; Methylpr | 2014 |
Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits.
Topics: Adipocytes; Adipogenesis; Animals; Anticholesteremic Agents; Bone Marrow Cells; Cell Size; Disease M | 2008 |
Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits.
Topics: Adrenal Cortex Hormones; Animals; Anticholesteremic Agents; Anticoagulants; Biomarkers; Chemoprevent | 2008 |
Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment.
Topics: Adrenal Cortex Hormones; Animals; Disease Models, Animal; Female; Femur; Femur Head Necrosis; Methyl | 2008 |
Protective effects of tadalafil on experimental spinal cord injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Carbolines; Disease Models, Animal; Glutathione; Male; Malondiald | 2010 |
To investigate the role of the nervous system of bone in steroid-induced osteonecrosis in rabbits.
Topics: Animals; Disease Models, Animal; Female; Femur Head; Femur Head Necrosis; Glucocorticoids; Methylpre | 2010 |
Pentosan reduces osteonecrosis of femoral head in SHRSP.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Femur Head Necrosis; Lipid Metabolism; Male; Met | 2010 |
Lipoic acid prevents steroid-induced osteonecrosis in rabbits.
Topics: Animals; Biomarkers; Cholesterol; Cytoprotection; Disease Models, Animal; Endothelins; Femur; Glutat | 2012 |
Chinchilla laniger can be used as an experimental model for Taenia solium taeniasis.
Topics: Animals; Anti-Inflammatory Agents; Chinchilla; Disease Models, Animal; Enzyme-Linked Immunosorbent A | 2011 |
Pulsed electromagnetic fields stimulation prevents steroid-induced osteonecrosis in rats.
Topics: Animals; Disease Models, Animal; Electromagnetic Fields; Gene Expression; Glucocorticoids; Injection | 2011 |
Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.
Topics: Adipocytes; Animals; Anti-Inflammatory Agents; Bone Marrow; Disease Models, Animal; Drinking Water; | 2012 |
[Platelet and endothelial cell-derived microparticles in steroid-induced osteonecrosis of the femoral head of rabbit model].
Topics: Animals; Antithrombin III; Blood Platelets; Disease Models, Animal; E-Selectin; Endothelial Cells; F | 2007 |
Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study.
Topics: Adipocytes; Animals; Bone Marrow Cells; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Disease Mod | 2008 |
Lysosomal enzyme levels and tumor growth in steroid-treated rat model.
Topics: Animals; Body Weight; Cathepsins; Disease Models, Animal; Female; Liver; Lysosomes; Mammary Neoplasm | 1980 |
Strongyloides stercoralis: histopathology of uncomplicated and hyperinfective strongyloidiasis in the Mongolian gerbil, a rodent model for human strongyloidiasis [corrected].
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Gerbillinae; Hemorrhage; Intestinal Disea | 1995 |
Na-K ATPase activity in murine glucocorticoid induced polycystic kidney disease in vivo.
Topics: Animals; Disease Models, Animal; Female; Kidney; Lectins; Male; Methylprednisolone; Methylprednisolo | 1993 |
Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus).
Topics: Animals; Animals, Newborn; Disease Models, Animal; Dogs; Female; Gerbillinae; Male; Methylprednisolo | 1993 |
Renal tubule Na,K-ATPase polarity in glucocorticoid-induced polycystic kidney disease.
Topics: Animals; Cell Polarity; Disease Models, Animal; Fluorescent Antibody Technique; Immunoenzyme Techniq | 1993 |
Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Disease Models, Animal; Epidermal Growth Factor | 1996 |
Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis.
Topics: Adipocytes; Animals; Blood Flow Velocity; Bone Marrow Cells; Cell Size; Disease Models, Animal; Femu | 2002 |
Methylprednisolone acetate induced release of cartilage proteoglycans: determination by high performance liquid chromatography.
Topics: Animals; Anti-Inflammatory Agents; Cartilage, Articular; Chromatography, High Pressure Liquid; Disea | 1992 |
Comparison of corticosteroid therapy in the prevention of pelvic tissue reaction and adhesion formation.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Betamethasone; Dexamethasone; Disease Mo | 1986 |
[Facial palsy of a short duration induced by compressing the extratemporal facial nerve].
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Facial Nerve; Facial Paralysis; Guinea Pi | 1985 |